Phibro Animal Health (PAHC) Cash & Current Investments (2013 - 2026)
Phibro Animal Health (PAHC) posted quarterly Cash & Current Investments of $77.5 million for Q1 2026, up 10.09% year-over-year from $70.4 million in Q1 2025, and up 3.95% quarter-over-quarter from $74.5 million in Q4 2025.
Phibro Animal Health (PAHC) Cash & Current Investments (2013 - 2026) Analysis & Trends
Phibro Animal Health's Cash & Current Investments history runs 14 years deep, the most recent figure standing at $77.5 million for Q1 2026.
- In Q1 2026, Cash & Current Investments rose 10.09% year-over-year to $77.5 million; the TTM figure through Mar 2026 stood at $77.5 million (up 10.09% YoY), while the FY2025 annual figure was $77.0 million, down 32.78% from the prior year.
- Cash & Current Investments for Q1 2026 stood at $77.5 million, up from $74.5 million in the prior quarter.
- The five-year high for Cash & Current Investments was $114.6 million in Q2 2024, with the low at $67.1 million in Q4 2024.
- The 5-year median for Cash & Current Investments is $85.3 million (2025), against an average of $85.1 million.
- The sharpest annual moves came in 2024 and 2025: Cash & Current Investments soared 41.01% in 2024, then slumped 32.78% in 2025.
- Phibro Animal Health's Cash & Current Investments stood at $78.4 million in 2022, then increased by 17.94% to $92.5 million in 2023, then slipped by 27.48% to $67.1 million in 2024, then grew by 11.08% to $74.5 million in 2025, then increased by 3.95% to $77.5 million in 2026.
- Business Quant data shows PAHC's Cash & Current Investments at $77.5 million in Q1 2026, $74.5 million in Q4 2025, and $85.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 963.33 Mn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 3.66 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 1.68 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 5.80 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 2.66 Bn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 886.50 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 389.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 530.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 164.00 Mn |
| 10 | Phibro Animal Health | 1.42 Bn | 1.35 Bn | 125.68 Mn | 77.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 77.45 Mn |
| Dec 31, 2025 | 74.51 Mn |
| Sep 30, 2025 | 85.27 Mn |
| Jun 30, 2025 | 77.04 Mn |
| Mar 31, 2025 | 70.35 Mn |
| Dec 31, 2024 | 67.07 Mn |
| Sep 30, 2024 | 89.84 Mn |
| Jun 30, 2024 | 114.61 Mn |
| Mar 31, 2024 | 98.75 Mn |
| Dec 31, 2023 | 92.49 Mn |
| Sep 30, 2023 | 91.15 Mn |
| Jun 30, 2023 | 81.28 Mn |
| Mar 31, 2023 | 77.24 Mn |
| Dec 31, 2022 | 78.42 Mn |
| Sep 30, 2022 | 86.28 Mn |
| Jun 30, 2022 | 91.25 Mn |
| Mar 31, 2022 | 92.85 Mn |
| Dec 31, 2021 | 95.49 Mn |
| Sep 30, 2021 | 97.18 Mn |
| Jun 30, 2021 | 93.21 Mn |